These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17135988)

  • 21. Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.
    Treatment for Adolescents With Depression Study Team
    J Am Acad Child Adolesc Psychiatry; 2003 May; 42(5):531-42. PubMed ID: 12707557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunctional attitudes scale perfectionism: a predictor and partial mediator of acute treatment outcome among clinically depressed adolescents.
    Jacobs RH; Silva SG; Reinecke MA; Curry JF; Ginsburg GS; Kratochvil CJ; March JS
    J Clin Child Adolesc Psychol; 2009 Nov; 38(6):803-13. PubMed ID: 20183664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
    ; March J; Silva S; Curry J; Wells K; Fairbank J; Burns B; Domino M; Vitiello B; Severe J; Riedal K; Goldman M; Feeny N; Findling R; Stull S; Baab S; Weller EB; Robbins M; Weller RA; Jessani N; Waslick B; Sweeney M; Dublin R; Walkup J; Ginsburg G; Kastelic E; Koo H; Kratochvil C; May D; LaGrone R; Vaughan B; Albano AM; Hirsch GS; Podniesinki E; Chu A; Reincecke M; Leventhal B; Rogers G; Jacobs R; Pathak S; Wells J; Lavanier SA; Danielyan A; Rohde P; Simons A; Grimm J; Frank S; Emslie G; Kennard B; Hughes C; Mayes TL; Rosenberg D; Benazon N; Butkus M; Bartoi M
    Am J Psychiatry; 2009 Oct; 166(10):1141-9. PubMed ID: 19723787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of treatments for adolescent depression: results from TADS.
    Domino ME; Burns BJ; Silva SG; Kratochvil CJ; Vitiello B; Reinecke MA; Mario J; March JS
    Am J Psychiatry; 2008 May; 165(5):588-96. PubMed ID: 18413703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical messages from the Treatment for Adolescents With Depression Study (TADS).
    March JS; Vitiello B
    Am J Psychiatry; 2009 Oct; 166(10):1118-23. PubMed ID: 19723786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
    Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
    J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
    Riggs PD; Mikulich-Gilbertson SK; Davies RD; Lohman M; Klein C; Stover SK
    Arch Pediatr Adolesc Med; 2007 Nov; 161(11):1026-34. PubMed ID: 17984403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).
    Lewis CC; Simons AD; Nguyen LJ; Murakami JL; Reid MW; Silva SG; March JS
    J Am Acad Child Adolesc Psychiatry; 2010 Feb; 49(2):132-40. PubMed ID: 20215935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extreme thinking in clinically depressed adolescents: Results from the Treatment for Adolescents with Depression Study (TADS).
    Jacobs RH; Reinecke MA; Gollan JK; Jordan N; Silva SG; March JS
    Behav Res Ther; 2010 Nov; 48(11):1155-9. PubMed ID: 20843506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study.
    Pathak S; Kratochvil CJ; Rogers GM; Silva S; Vitiello B; Weller EB; March JS
    Curr Psychiatry Rep; 2005 Dec; 7(6):429-34. PubMed ID: 16318820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glad for what TADS adds, but many TADS grads still sad.
    Brent DA
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1461-4. PubMed ID: 17135991
    [No Abstract]   [Full Text] [Related]  

  • 32. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Moore J; Jones JM; Foxwell AA; King J
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):991-8. PubMed ID: 26598474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Zhu L; Tao R; Hughes C; Croarkin P
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):21-8. PubMed ID: 22257126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors and moderators of response to cognitive behavioral therapy and medication for the treatment of binge eating disorder.
    Grilo CM; Masheb RM; Crosby RD
    J Consult Clin Psychol; 2012 Oct; 80(5):897-906. PubMed ID: 22289130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of depression treatment for adolescents.
    Norquist G; McGuire TG; Essock SM
    Am J Psychiatry; 2008 May; 165(5):549-52. PubMed ID: 18450932
    [No Abstract]   [Full Text] [Related]  

  • 38. Turning darkness into light. A new landmark study on the treatment of adolescent depression. Comments on the TADS study.
    Apter A; Kronenberg S; Brent D
    Eur Child Adolesc Psychiatry; 2005 May; 14(3):113-6. PubMed ID: 15959656
    [No Abstract]   [Full Text] [Related]  

  • 39. A placebo prognostic index (PI) as a moderator of outcomes in the treatment of adolescent depression: Could it inform risk-stratification in treatment with cognitive-behavioral therapy, fluoxetine, or their combination?
    Lorenzo-Luaces L; Rodriguez-Quintana N; Riley TN; Weisz JR
    Psychother Res; 2021 Jan; 31(1):5-18. PubMed ID: 32223373
    [No Abstract]   [Full Text] [Related]  

  • 40. Trajectories of Functioning Into Emerging Adulthood Following Treatment for Adolescent Depression.
    Peters AT; Jacobs RH; Feldhaus C; Henry DB; Albano AM; Langenecker SA; Reinecke MA; Silva SG; Curry JF
    J Adolesc Health; 2016 Mar; 58(3):253-9. PubMed ID: 26576820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.